| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell and Transport Physiology |
,


* Department of Medicine, University of Louisville, Louisville, Kentucky;
Department of Medicine, University of Maryland, Baltimore, Maryland;
Veterans Administration Medical Center, Baltimore, Maryland;
Department of Biology, University of Memphis, Memphis, Tennessee; and || Veterans Administration Medical Center, Louisville, Kentucky
Address correspondence to: Dr. Syed Jalal Khundmiri, University of Louisville, Kidney Disease Program, 570 South Preston Street, Baxter I Building, Suite 102, Louisville, KY 40202. Phone: 502-852-0014; Fax: 502-852-4384; E-mail: syed.khundmiri{at}louisville.edu
Received for publication December 6, 2004. Accepted for publication June 6, 2005.
| Abstract |
|---|
|
|
|---|
1 subunit when compared with OK-WT cells. PTH decreased Na+,K+-ATPase activity and stimulated phosphorylation of the Na+,K+-ATPase
1 in OK-WT cells but not in NHERF-deficient cells. Rubidium (86Rb) uptake was equivalent in OK-WT, OKH, and OKH cells that were transfected with all but the double PDZ domain mutants. PTH decreased 86Rb uptake significantly in OK-WT but not in OKH cells. PTH also significantly inhibited 86Rb uptake in OKH cells that were transfected with full-length NHERF-1 or NHERF-1 with mutated PDZ 2 but not in OKH cells that were transfected with mutated PDZ 1. Transfection with NHERF expressing both mutated PDZ domains resulted in diminished basal 86Rb uptake that was not inhibited further by PTH. PTH stimulated protein kinase C
activity and
1 subunit phosphorylation in OK-WT but not in NHERF-deficient cells. Transfection of OKH cells with NHERF constructs that contained an intact PDZ1 domain restored PTH-stimulated protein kinase C
activity and
1 subunit phosphorylation. These results demonstrate that NHERF-1 is necessary for PTH-mediated inhibition of Na+,K+-ATPase activity and that the inhibition is mediated through the PDZ1, not PDZ2, domain. | Introduction |
|---|
|
|
|---|
Mahon et al. (4,5) demonstrated a critical role for sodium hydrogen exchanger regulatory factor (NHERF) in the regulation of PTH receptor signaling. NHERF are PDZ (PSD-95, Drosophila discs large, ZO-1) proteins that are centrally involved in regulation of proximal renal tubule cell transport processes (611). Two members of the NHERF family have been described to exhibit unique expression patterns and functions in kidney (1215). In mouse kidney, NHERF-1 is expressed predominantly in the microvilli of the proximal tubule in association with NHE-3, the type IIa sodium-phosphate co-transporter (NaPi IIa), and ezrin and is responsible for facilitation of cAMP-mediated regulation of NHE-3 and apical membrane targeting of NaPi IIa. NHERF-2 is expressed at the base of the microvilli associated with NHE-3 and ezrin but not NaPi IIa and facilitates calcium-mediated regulation of NHE-3.
The two distinct PDZ domains of NHERF exhibit divergent amino acid sequences and binding specificities that permit the construction and localization of extended heterogeneous protein interaction units (1618). For example, the N terminal PDZ domain (amino acids 77 to 82; PDZ1) binds to the
2 adrenergic receptor (19), NaPi IIa (20), phospholipase C (PLC)
1,2 (21), and RACK-1 (22), whereas the C terminal PDZ domain (amino acids 217 to 222; PDZ2) binds to NHE-3 (23) and ROMK (24). Some proteins, notably the cystic fibrosis conductance regulator, are capable of binding either PDZ domain (25,26).
We recently demonstrated that expression of a murine NHERF-1 construct lacking the C-terminal ezrin-binding domain (amino acids 325 to 355) completely abolishes regulation of Na+,K+-ATPase activity by PTH in opossum kidney (OK) cells, a model of mammalian renal proximal tubule (27). The role of the two PDZ domains of NHERF-1 in the regulation of Na+,K+-ATPase activity and expression remains unknown. Binding of NHE-3 to the PDZ2 domain of NHERF-1 is necessary for its regulation by PTH (23). In addition, Breton et al. and others (28,29) have shown that the B1 subunit of H+-ATPase, a member of the V-type ATPases, co-localizes through its PDZ-binding domain with NHERF. On the basis of these observations, we hypothesized that one or both PDZ domains of NHERF are also required for PTH regulation of Na+,K+-ATPase.
To address this hypothesis, we compared the ability of PTH to regulate
1 subunit phosphorylation and Na+,K+-ATPase activity in wild-type OK cells (OK-WT) and in two models of NHERF-deficient OK cells. OK-WT cells express only NHERF-1 and not NHERF-2, making them an excellent model to investigate the role of this specific NHERF isoform in regulation of transport in the proximal renal tubule cell (30). To examine the specific role of the two PDZ domains, we stably transfected a NHERF-deficient OK cell line, OKH cells (3133), with either full-length human NHERF-1 or NHERF-1 constructs expressing nonfunctional PDZ 1, PDZ 2, or both PDZ domains. We demonstrated that the ability of PTH to phosphorylate the
1 subunit and to regulate Na+,K+-ATPase activity was dependent on the expression of NHERF-1 with a normal PDZ 1 domain.
| Materials and Methods |
|---|
|
|
|---|
1-subunit (for immunoprecipitation [IP]) and protein kinase C (PKC) activity kit were purchased from Upstate Biotechnology (Waltham, MA). MAb against Na+,K+-ATPase
1-subunit (for Western blots) were purchased from Sigma-RBI (Natick, MA). Antibodies against ezrin were purchased from Sigma (St. Louis, MO). Antibodies against PKC
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phosphoserine antibodies were purchased from Zymed (San Francisco, CA). Geneporter transfection and Genesilencer siRNA transfection reagents were purchased from Gene Therapy Systems Inc. (San Diego, CA). All other chemicals were purchased from Sigma unless otherwise specified. Anti-NHERF antibodies were previously characterized by E.J.W. and his colleagues (14).
NHERF Mutations
The human NHERF-1 cDNA was inserted into pET-30-(a)+ (Novagen, Madison, WI) to generate a hexahistidine-fused NHERF-1 (His-NHERF-1), which then was transferred to pcDNA 3.1Hygro+ for expression in mammalian cells. Similarly, cDNA encoding NHERF-1 with alanine substitutions (GAGA) in the core peptide-binding sequence, GYGF (amino acids 77 to 82 and 217 to 222), that inactivates the individual PDZ domains were inserted into pcDNA 3.1Hygro+. All cDNA were confirmed by double-stranded DNA sequencing (23).
| Cell Culture |
|---|
|
|
|---|
Preparation and Purification of NHERF siRNA
NHERF siRNA sense and antisense oligonucleotides were designed by using Ambions web-based siRNA converter software (Austin, TX). The software identified a unique sequence (5'-AAGUCUAAGCCAGGCCAGGUUC-3') in the N-terminal region of NHERF against which siRNA was designed. The siRNA was prepared by using siRNA construction kit from Ambion according to the manufacturers protocol. Briefly, sense and antisense oligonucleotides were hybridized separately to T7 promoter primer followed by a Klenow DNA polymerase reaction. The sense and antisense siRNA templates were transcribed independently using T7 enzyme and mixed to form double-stranded siRNA (dsRNA). The siRNA was digested with RNase and DNase to remove the 5' overhanging leader sequences and DNA template. The resulting siRNA was purified by column purification.
Transfection of siRNA
One microgram of NHERF siRNA was transfected into OK cells using Genesilencer Transfection reagent according to the manufacturers protocol. Briefly, 5 µl of Genesilencer reagent was diluted with 25 µl of serum-free EMEM. In another tube, 1 µg of siRNA was diluted in 25 µl of siRNA diluent and 15 µl of serum-free EMEM. The siRNA-containing mixture was mixed with diluted Genesilencer reagent and incubated at room temperature for 15 min. The siRNA Genesilencer reagent mixture was added onto growing cells in serum-free EMEM and incubated at 37°C in 95% air/5% CO2 for 6 h, after which 1 ml of EMEM that contained 20% serum was added and further incubated for 24 h at 37°C in 95% air/5% CO2.
NHERF cDNA Transfection
Vector (pcDNA 3.1Hygro+) or human NHERF-1 and PDZ mutated human NHERF cDNA constructs in pcDNA 3.1Hygro+ were transfected into OKH cells using Geneporter transfection reagent according to the manufacturers protocol. Briefly, the cDNA and the Geneporter reagent were diluted separately in serum-free medium. The diluted cDNA was mixed with diluted Geneporter reagent and incubated at room temperature for 30 min. The culture medium from the cells was replaced with the mixture that contained Geneporter and NHERF cDNA and incubated for 24 h at 37°C in 95% air/5% CO2. The transfected cells were selected by growing them in 1000 U/ml hygromycin in a 96-well cell culture plate for 2 wk. Cells from the hygromycin-resistant wells were grown in DMEM/F12 that contained 600 U/ml hygromycin and 10% FCS. Expression of NHERF was confirmed by Western blot analysis.
Treatment with PTH
Unless otherwise stated, cells were treated for 15 min with 107 M PTH 1 to 34 at 37°C in 95% air/5% CO2.
Membrane Preparation
The cells were treated with 107 M PTH (bovine, 1 to 34) or vehicle, washed twice with PBS, and homogenized in 50 mM mannitol/5 mM Tris (pH 7.4), and the crude membranes were prepared as described previously (27).
Western Blot
Western blot analysis for NHERF, Na+,K+-ATPase
1 subunit, PKC
, and ezrin was performed exactly as described previously (27).
Determination of Na+,K+-ATPase Activity as K+-Dependent pNPPase Activity
Na+,K+-ATPase activity was measured as described previously (27) following the method of Hird et al. (35) with slight modifications as described by Tran and Farley (36).
Immunoprecipitation
The crude membranes were solubilized in IP buffer that contained 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 20 mM NaF, 1 mM EDTA, 1 mM EGTA, 5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 1 mM sodium pyrophosphate, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1% Triton X-100, 0.5% NP40, and 0.5% SDS and centrifuged at 70,000 x g for 1 h in a Beckman ultracentrifuge. Na+,K+-ATPase
1-subunit or PKC
was immunoprecipitated from 100 µg of supernatant protein overnight at 4°C as described previously (37). Western blotting was performed as previously reported (27).
Rubidium Uptake
Ouabain-sensitive rubidium (86Rb) uptake was measured as an index of Na+,K+-ATPasemediated ion transport as described previously (37) following the method of Okafor et al. (38).
Determination of PKC
Activity
OK cells were incubated in the presence or absence of 107 M PTH for 15 min. The cells were washed two times with PBS (pH 7.4) and lysed in IP buffer. PKC
was immunoprecipitated from 100 µg of whole-cell lysate protein as described above. The beads were washed three times with IP buffer, and PKC activity was determined as described previously (37).
Confocal Imaging
Multichambered coverglass wells (Nunc, Naperville, CT) were seeded with OK cells. Cells were washed with serum-free medium 24 h before fixation. Cells were rinsed three times with PBS that contained calcium and magnesium, incubated in 4% paraformaldehyde in PBS for 10 min, rinsed five times with PBS, solubilized with 0.025% saponin in PBS for 15 min, incubated with an appropriate dilution of primary antibody (1:250 in PBS-Saponin for both NHERF and Na+,K+-ATPase
1 subunit antibodies) at 20°C, rinsed five times with PBS-Saponin, and incubated with appropriate Alexaflour secondary antibody (1:1000) conjugated to different fluorescence tags at 20°C. Alexaflour488 was used for identification of NHERF, and Alexaflour555 was used for identification of the
subunit. The cells were rinsed five times with PBS-Saponin, incubated with 300 nM DAPI for 5 min, rinsed three times with PBS, and mounted with 300 µl/well PBS. Images were acquired using a Zeiss confocal microscope and analyzed using LSM510 software. Z scan analysis on single cells was performed by scanning at 1-µm intervals and three-dimensional reconstruction of the fluorescence images. The images for NHERF and for the
subunit were merged in a single image to compare the cellular distribution of the two proteins.
Brush border membranes (BBM) and BLM were prepared from the same cell preparations as described previously (3,39). Protein concentration was measured by BCA method (Sigma) using BSA as standard.
Statistical Analyses
Data are shown as mean ± SEM. All experiments were repeated at least three times unless otherwise stated to document reproducibility. P value was calculated using SigmaStat software using paired t test. P < 0.05 was a priori considered statistically significant.
| Results |
|---|
|
|
|---|
1 subunit and ezrin in OKH cells was equivalent to OK-WT. The Western blot also indicates that PTH did not change the expression of Na+,K+-ATPase
1 subunit and ezrin in the crude membranes from OK-WT and OKH cells. We also developed from WT-OK strains with diminished NHERF-1 expression through the use of siRNA technology. Immunoblot analysis of NHERF siRNA OK-WT shows a marked reduction in NHERF-1 expression but intact expression of Na+,K+-ATPase
1 subunit and ezrin.
|
|
1 Subunit Phosphorylation
1 subunit accompanied by endocytosis of the subunit, resulting in decreased enzyme expression on the plasma membrane and therefore decreased activity (40). We previously demonstrated that expression of the NHERF construct lacking the ezrin-binding domain blocked PTH-stimulated phosphorylation of the
1 subunit (27). To determine whether NHERF deficiency had a similar inhibitory effect on PTH regulation, we measured PTH-stimulated phosphorylation of the
1 subunit in OK-WT, OKH, and NHERF siRNA OK-WT cells. As shown in Figure 3, PTH stimulated phosphorylation of Na+,K+-ATPase
1 subunit in OK-WT cells but not in NHERF-deficient models.
|

through an extracellular signal-regulated kinase (ERK)-dependent pathway is critical for regulation of Na+,K+-ATPase activity (37). To determine whether PTH-stimulated activation of these signaling pathways was impaired in NHERF-deficient OKH cells, we examined the ability of PTH to stimulate ERK phosphorylation and PKC
translocation to the membrane fragment. As shown in Figure 4A, PTH stimulation of ERK phosphorylation is intact in the OKH model system. Western blot analysis of PKC
in the membrane fraction (Figure 4B) shows PTH-stimulated increased membrane expression of PKC
in OK-WT but not in NHERF-deficient OKH cells. A concomitant decrease in the PKC
expression was observed in the cytosol from OK-WT cells (data not shown).
|
1 subunit. Treatment with 107 M PTH for 15 min produced a significant inhibition in ouabain-sensitive 86Rb uptake, a measure of Na+,K+-ATPase activity, in OK-WT but not in OKH cells (Figure 5B). Transfection of full-length NHERF to OKH cells restored normal inhibition of 86Rb uptake by PTH, confirming that the defect in PTH regulation of Na+,K+-ATPase activity in OKH cells was due to NHERF deficiency. Basal Na+,K+-ATPasemediated 86Rb uptake was significantly decreased in OKH cells that were transfected with NHERF construct expressing both PDZ mutations compared with the OK-WT or OKH cells and did not change significantly upon treatment with PTH. Similar to OKH cells that were transfected with full-length NHERF, cells expressing the PDZ2 mutation showed normal PTH-mediated inhibition of 86Rb uptake.
|
1 subunit of Na+,K+-ATPase (Figure 6A) and activate PKC
(Figure 6B). As expected, PTH stimulated phosphorylation in OK-WT but not in OKH cells. Cells that were transfected with full-length NHERF or the NHERF construct expressing the mutated PDZ2 domain showed partial restoration of PTH-stimulated phosphorylation of the
1 subunit. In contrast, OKH cells that were transfected with the construct expressing the mutated PDZ1 domain failed to undergo
1 subunit phosphorylation in response to PTH. OKH cells that were transfected with the NHERF construct expressing both PDZ domain mutations have significantly increased basal phosphorylation of the
1 subunit that did not change with PTH treatment, indicated by densitometric analysis. PTH caused an approximately 50% increase in PKC
activity in OK-WT but not in OKH cells. PTH also significantly increased the activity of PKC
in OKH cells that were transfected with full-length NHERF-1 and PDZ2 mutated NHERF-1 but not in PDZ1 or both PDZ domainmutated NHERF-1transfected OKH cells.
|
1 Subunit
1 subunit (red fluorescence). OK-WT cells (Figure 7A) demonstrate a pattern of predominantly basolateral distribution of the
1 subunit. NHERF staining was observed at both the apical and the basolateral sides. OKH cells show a similar distribution for the
1 subunit but no detectable NHERF (Figure 7B). Figure 7C shows the distribution of NHERF and the
1 subunit in OKH cells that were transfected with full-length NHERF, demonstrating that the transfected protein assumes a similar distribution as the OK-WT cells. Similar distribution of NHERF and Na+,K+-ATPase
1 subunit was observed in NHERF mutant constructtransfected (PDZ1, PDZ2, and both PDZ domains) cells as seen in WT cells (data not shown). As other investigators have not consistently demonstrated basolateral expression of NHERF, BBM and BLM were prepared and subjected to Western blot analysis. As shown in Figure 7D, NHERF expression is observed in both the BBM and BLM preparations. BBM and BLM preparations were confirmed by Western blot analysis of NaPi-4 and Na+,K+-ATPase
1 subunit (Figure 7D, bottom).
|
| Discussion |
|---|
|
|
|---|
1, and actin. The authors showed that introduction into the cells of a peptide sequence identical to the PDZ1 domain of NHERF impaired apical membrane PTH1 receptor localization presumably through competition for binding of the PTH1 receptor and blocked PTH-stimulated intracellular calcium release.
Failure of PTH to inhibit Na+,K+-ATPase activity in the NHERF-deficient cells was accompanied by a failure to stimulate phosphorylation of the
1 subunit, which could be explained by a decrease in
1 subunit expression, failure to activate appropriate kinases, or inability of the kinases to reach the appropriate substrate. Both models of NHERF-deficient OK cells exhibited
1 subunit expression and baseline Na+,K+-ATPase activity that was equivalent to OK-WT. These findings, coupled with the confocal imaging studies, suggest that NHERF very likely does not play a dominant role in the plasma membrane localization of the components of the sodium pump. The diminished basal rubidium uptake in PDZ double-mutant cells despite the equivalent expression of the
1 subunit in the crude membrane preparation is somewhat at variance with this conclusion. As rubidium uptake tends to correlate with surface expression of the
1 subunit, this finding suggests that in OKH cells with the double PDZ mutation,
1 subunit may not be as efficiently expressed in the plasma membrane or may not be as fully active as WT. Further studies will be required to determine the effect of double mutations in NHERF PDZ domains in regulation of Na+,K+-ATPase activity and expression.
Our demonstration that the inability of PTH to inhibit sodium pump activity is correlated with an inability to activate PKC
in NHERF-deficient cells is consistent with previously published data from the laboratories of Cole (32,33) and of Mahon and Segre (4,5). Cole et al. (32) demonstrated that PTH stimulation of PKA in NHERF-deficient OKH cells was intact but that stimulation of intracellular calcium transients was not. Mahon et al. (4) furthered these observations by showing that NHERF-deficient OKH cells exhibit impaired activation of PLC through disruption of the protein complex required for PTH activation of this pathway. Whether the BLM of OK cells express the membrane protein complexes similar to those described in the apical membrane is not known. We showed recently that PTH activation of PKC
is essential for regulation of sodium pump activity and that the activation is ERK dependent (37). PTH stimulation of ERK phosphorylation is intact in NHERF-deficient cells, suggesting that activation of PKC
by PTH may depend on the simultaneous additive effects of both ERK and PLC.
From our data, we cannot determine the molecular mechanisms by which the PDZ1 domain mutation abolishes PTH regulation of the sodium pump. The mutation in the PDZ1 domain could result in a change in protein binding specific to the domain, or the mutation could result in misfolding that alters functions of the protein beyond the PDZ domain. Our confocal data show that the mutated NHERF traffics to the membrane in a normal distribution, suggesting that any misfolding that might occur is not as profound as to result in aberrant localization or in premature degradation. The question remains as to whether NHERF-1 binds the
1 subunit of Na+,K+-ATPase. Our confocal images and Western blots of isolated BLM show some localization of NHERF to the basolateral surface, suggesting that a direct NHERF-
subunit interaction could exist, contrasting the findings of Hernando et al. (20). These results, however, confirm the previous results by Bernardo et al. (41), who showed NHERF expression in BLM from rabbit kidney proximal tubules. From our data, we cannot determine whether NHERF binds directly to the
1 subunit of Na+,K+-ATPase. Scan of the sequence for the
1 subunit fails to disclose any known PDZ binding domain. These results do not exclude the possible presence of a nonclassical binding motif. Alternatively, the PDZ1 domain could mediate the association of the
1 subunit with the PTH1 receptor through interactions with other intermediary proteins, such as the
subunit or the
subunit, or some other component of a signaling complex such as G
q (4246).
In conclusion, we have demonstrated that expression of the PDZ1 domain of NHERF-1 is critical for PTH regulation of Na+,K+-ATPase activity in renal proximal tubule cells. The role of this domain is to facilitate PTH receptor activation of the PLC/PKC pathway, a pathway that is critical for the phosphorylation and endocytosis of the
1 subunit of the sodium pump. Our findings also highlight contrasts between the mechanisms by which NHERF-1 mediates PTH regulation of two different transporters, the sodium pump and NHE-3. For the sodium pump, the PDZ1 domain of NHERF is required for PLC/PKC-mediated phosphorylation of the
subunit by facilitating the activation of this signaling pathway by PTH. For NHE-3, the PDZ2 domain of NHERF is required for PKA-mediated phosphorylation of the protein. These findings open the door to new mechanisms by which PTH can exert individualized regulation on its target proteins.
| Acknowledgments |
|---|
We acknowledge the technical assistance of Nina Lesousky.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y.-C. Chen, R. K. Meier, S. Zheng, S. J. Khundmiri, M. T. Tseng, E. D. Lederer, P. N. Epstein, and B. J. Clark Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules Am J Physiol Renal Physiol, August 1, 2009; 297(2): F380 - F388. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hosojima, H. Sato, K. Yamamoto, R. Kaseda, T. Soma, A. Kobayashi, A. Suzuki, H. Kabasawa, A. Takeyama, K. Ikuyama, et al. Regulation of Megalin Expression in Cultured Proximal Tubule Cells by Angiotensin II Type 1A Receptor- and Insulin-Mediated Signaling Cross Talk Endocrinology, February 1, 2009; 150(2): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Khundmiri, M. Ameen, N. A. Delamere, and E. D. Lederer PTH-mediated regulation of Na+-K+-ATPase requires Src kinase-dependent ERK phosphorylation Am J Physiol Renal Physiol, August 1, 2008; 295(2): F426 - F437. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Khundmiri, A. Ahmad, R. E. Bennett, E. J. Weinman, D. Steplock, J. Cole, P. D. Baumann, J. Lewis, S. Singh, B. J. Clark, et al. Novel regulatory function for NHERF-1 in Npt2a transcription Am J Physiol Renal Physiol, April 1, 2008; 294(4): F840 - F849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Voltz, M. Brush, S. Sikes, D. Steplock, E. J. Weinman, and S. Shenolikar Phosphorylation of PDZ1 Domain Attenuates NHERF-1 Binding to Cellular Targets J. Biol. Chem., November 16, 2007; 282(46): 33879 - 33887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Murtazina, O. Kovbasnjuk, N. C. Zachos, X. Li, Y. Chen, A. Hubbard, B. M. Hogema, D. Steplock, U. Seidler, K. M. Hoque, et al. Tissue-specific Regulation of Sodium/Proton Exchanger Isoform 3 Activity in Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) Null Mice: cAMP INHIBITION IS DIFFERENTIALLY DEPENDENT ON NHERF1 AND EXCHANGE PROTEIN DIRECTLY ACTIVATED BY cAMP IN ILEUM VERSUS PROXIMAL TUBULE J. Biol. Chem., August 24, 2007; 282(34): 25141 - 25151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wu, H. Kausar, P. Johnson, D. E. Montoya-Durango, M. Merchant, and M. J. Rane Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex J. Biol. Chem., July 27, 2007; 282(30): 21598 - 21608. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |